← 產業報告目錄

IoT Medical Devices Market by Product (Wearable (Vital Sign (BP, Glucose, ECG, Oximeter), Resp., Fetal), Implant (Neuro, Cardiac-Defib, Pacemaker) Pumps), Connectivity (Bluetooth, WiFi), End User (Hospital, Nursing Home) & Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-06-13頁數 330報告編號 HIT6543

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global IoT medical devices market is projected to reach USD 154.74 billion by 2030, up from USD 65.08 billion in 2025, reflecting a CAGR of 18.9% during this period. The market is growing rapidly due to an increasing demand for continuous and real-time patient monitoring, particularly with the wider adoption of telehealth. Recent innovations in low-energy sensors, 5G networks, and edge computing have made it possible to efficiently collect and transmit data from wearable and implantable devices to healthcare systems. These advancements enable more proactive and decentralized care, leading to fewer hospital readmissions. Furthermore, the rising incidence of chronic conditions and an aging global population are driving the greater use of these technologies in both home and clinical settings. However, the market faces challenges, such as the complexity of integrating with legacy health IT infrastructure, compliance with data privacy regulations like HIPAA and GDPR, and the need to maintain strong cybersecurity to protect patient information in an increasingly connected ecosystem. “The hospitals & clinics segment, under the IoT medical devices market, is expected to register the fastest growth during the forecast period.” In 2024, the hospitals & clinics segment emerged as the leading end user segment in the IoT medical devices market, a position it is expected to maintain in the coming years. This leadership is primarily due to the increasing demand for advanced diagnostic, monitoring, and treatment tools within healthcare facilities. By adopting IoT-enabled technologies, these institutions can enhance patient outcomes through real-time data monitoring, remote care capabilities, and streamlined clinical operations. The ability to continuously track patient vital signs and chronic health conditions allows for quicker interventions and more effective care delivery. Additionally, the integration of IoT with electronic health records (EHRs) and clinical decision-making platforms improves data accuracy and fosters better coordination among care teams. Key factors driving this trend include the push for higher efficiency, rising patient volumes, and the necessity to meet stringent regulatory and quality standards. As a result, hospitals and clinics are making substantial investments in IoT technologies to improve performance, ensure compliance, and provide more responsive, personalized patient care. “Bluetooth-enabled IoT technology is projected to dominate the IoT medical devices market during the forecast period.” Bluetooth-enabled IoT technology is rapidly emerging as the fastest-growing connectivity option in the IoT medical devices market. This growth is primarily driven by its energy efficiency, easy integration, and wide compatibility with smartphones, tablets, and wearable healthcare devices. As more healthcare organizations adopt connected solutions for continuous monitoring and patient interaction, Bluetooth has become a reliable and cost-effective method for short-range data exchange. It plays a vital role in devices such as fitness trackers, mobile diagnostic equipment, and home health monitoring tools, where low power consumption and consistent data transfer are crucial. “Asia Pacific is expected to register fastest market growth during the forecast period.” The Asia Pacific region is expected to experience the fastest growth in the IoT medical devices market during the forecast period. This growth is primarily driven by the rapid adoption of digital healthcare technologies, including IoT and artificial intelligence. Government initiatives aimed at improving healthcare infrastructure, combined with significant investments in smart hospitals and digital health platforms, are leading to the increased deployment of connected medical devices. Additionally, the rising demand for remote monitoring solutions, fueled by a growing elderly population and an increase in chronic health conditions, is further propelling this trend. Furthermore, enhanced telecommunications networks and supportive regulatory frameworks for digital health services are facilitating the implementation of IoT-based solutions. As a result, Asia-Pacific is emerging as a key player in the global expansion of the IoT medical device industry. The breakdown of primary participants is as mentioned below: • By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25% • By Designation - C-level: 42%, Director-level: 31%, and Others: 27% • By Region - North America: 32%, Asia Pacific: 32%, Europe: 26%, Latin America: 5% and Middle East & Africa: 5% Key Players in the IoT Medical Devices Market The key players functioning in the IoT medical devices market include Medtronic (Ireland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott (US), Boston Scientific Corporation (US), OMRON Corporation (Japan), Baxter International Inc. (US), BIOTRONIK (Germany), Johnson & Johnson Private Limited (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Honeywell International Inc. (US), AliveCor, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Nonin (US), AMD Global Telemedicine (US), iHealth Labs Inc (US), Aerotel Medical Systems (1998) Ltd. (Israel), i-SENS, Inc. (Korea), Huntleigh Healthcare Limited (UK), ResMed (US), Masimo (US), Infinium Medical (US), ICU Medical, Inc. (US), and Hamilton Medical (Switzerland). Research Coverage The report analyzes the IoT medical devices market and aims to estimate the market size and future growth potential of various market segments based on product, type, connectivity technology, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report This report will provide valuable insights for both, established companies and new or smaller firms, helping them understand market trends and dynamics. By doing so, they can increase their market share. Companies that purchase this report can employ one or more of the strategies outlined below to enhance their positions in the market. This report provides insights on: • Analysis of key drivers: Drivers (government initiatives to promote digital health), restraints (high deployment cost of connected medical devices), opportunities (low doctor-to-patient ratio in several countries), and challenges (data security issues) are key factors influencing the growth of the IoT medical devices market • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the IoT medical devices market • Market Development: Comprehensive information on the lucrative emerging markets, product, type, connectivity technology, end user, and region • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the IoT medical devices market • Competitive Assessment: In-depth assessment of market ranking, growth strategies, product offerings, and capabilities of the leading players in the IoT medical devices market like Medtronic (Ireland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott (US), and Boston Scientific Corporation (US)
目錄 Table of Contents
1 INTRODUCTION 28 1.1 STUDY OBJECTIVES 28 1.2 MARKET DEFINITION 28 1.3 MARKET SCOPE 29 1.3.1 MARKETS COVERED 29 1.3.2 INCLUSIONS AND EXCLUSIONS 29 1.3.3 YEARS CONSIDERED 30 1.3.4 CURRENCY CONSIDERED 30 1.4 STAKEHOLDERS 30 1.5 SUMMARY OF CHANGES 31 2 RESEARCH METHODOLOGY 32 2.1 RESEARCH DESIGN 32 2.1.1 RESEARCH DATA 32 2.1.2 SECONDARY SOURCES 32 2.1.2.1 Key data from secondary sources 33 2.1.3 PRIMARY SOURCES 33 2.1.3.1 Key data from primary sources 34 2.1.3.2 Key industry insights 35 2.2 MARKET SIZE ESTIMATION 36 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39 2.4 LIMITATIONS 40 2.5 MARKET SHARE ANALYSIS 40 2.6 ASSUMPTIONS 40 2.7 RISK ASSESSMENT 40 3 EXECUTIVE SUMMARY 41 4 PREMIUM INSIGHTS 46 4.1 IOT MEDICAL DEVICES MARKET OVERVIEW 46 4.2 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY TYPE AND COUNTRY 47 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES IN IOT MEDICAL DEVICES MARKET 48 4.4 REGIONAL MIX: IOT MEDICAL DEVICES MARKET 48 4.5 IOT MEDICAL DEVICES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 49   5 MARKET OVERVIEW 50 5.1 INTRODUCTION 50 5.2 MARKET DYNAMICS 50 5.2.1 DRIVERS 51 5.2.1.1 Government initiatives to promote digital health 51 5.2.1.2 Growing need for cost-containment in healthcare delivery 52 5.2.1.3 Rising focus on patient engagement and patient-centric healthcare 53 5.2.1.4 Evolution of high-speed networking technologies 53 5.2.1.5 Growing focus on patient safety 54 5.2.2 RESTRAINTS 55 5.2.2.1 High deployment costs of connected medical devices 55 5.2.2.2 Lack of skilled IT personnel across healthcare organizations 55 5.2.3 OPPORTUNITIES 56 5.2.3.1 Low doctor-to-patient ratio in several countries 56 5.2.4 CHALLENGES 56 5.2.4.1 Data security issues 56 5.2.4.2 Data management and interoperability concerns 60 5.3 INDUSTRY INSIGHTS 60 5.3.1 INCREASING NUMBER OF PRODUCT LAUNCHES 60 5.3.2 GROWING INTEGRATION OF CLOUD PLATFORMS AND SAAS IN HEALTHCARE ECOSYSTEM 61 5.3.3 INCREASING NUMBER OF COLLABORATIONS TO DRIVE INNOVATION 62 5.4 TECHNOLOGY ANALYSIS 62 5.5 PORTER’S FIVE FORCES ANALYSIS 63 5.5.1 INTENSITY OF COMPETITIVE RIVALRY 64 5.5.2 BARGAINING POWER OF SUPPLIERS 64 5.5.3 BARGAINING POWER OF BUYERS 64 5.5.4 THREAT OF NEW ENTRANTS 64 5.5.5 THREAT OF SUBSTITUTES 65 5.6 KEY STAKEHOLDERS AND BUYING CRITERIA 65 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS 65 5.6.2 BUYING CRITERIA 66 5.7 REGULATORY ANALYSIS 66 5.7.1 NORTH AMERICA 66 5.7.1.1 US 66 5.7.1.2 Canada 71 5.7.2 EUROPE 71 5.7.3 ASIA PACIFIC 72 5.7.3.1 Japan 72 5.7.3.2 China 73 5.7.3.3 India 73   5.8 VALUE CHAIN ANALYSIS 74 5.9 ECOSYSTEM ANALYSIS 75 5.10 PRICING ANALYSIS 75 5.11 PATENT ANALYSIS 76 5.11.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 76 5.11.2 LIST OF MAJOR PATENTS 78 5.12 CASE STUDY ANALYSIS 80 5.12.1 CASE STUDY 1: ADVANCING WOUND MEASUREMENT ACCURACY IN HEALTHCARE WITH IOT TECHNOLOGY 80 5.12.2 CASE STUDY 2: EMPOWERING PATIENT-CONTROLLED PAIN MEDICATION ADMINISTRATION WITH IOT TECHNOLOGY 80 5.12.3 CASE STUDY 3: IMPROVING MATERNAL AND FETAL CARE WITH IOT-DRIVEN MONITORING SOLUTIONS 81 5.13 KEY CONFERENCES AND EVENTS, 2025–2026 81 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 5.15 IMPACT OF 2025 US TARIFFS—IOT MEDICAL DEVICES MARKET 82 5.15.1 INTRODUCTION 82 5.15.2 KEY TARIFF RATES 83 5.15.3 PRICE IMPACT ANALYSIS 84 5.15.4 IMPACT ON COUNTRY/REGION 85 5.15.4.1 US 85 5.15.4.2 Europe 86 5.15.4.3 Asia Pacific 87 5.15.5 IMPACT ON END-USE INDUSTRIES 88 6 IOT MEDICAL DEVICES MARKET, BY PRODUCT 91 6.1 INTRODUCTION 92 6.2 VITAL SIGNS MONITORING DEVICES 93 6.2.1 BLOOD GLUCOSE MONITORS 94 6.2.1.1 Preference for continuous glucose monitoring to drive market 94 6.2.2 ECG/HEART RATE MONITORS 95 6.2.2.1 Rising incidence of CVD to drive market growth 95 6.2.3 BLOOD PRESSURE MONITORS 98 6.2.3.1 Growing prevalence of hypertension and obesity to fuel market 98 6.2.4 MULTIPARAMETER MONITORS 100 6.2.4.1 Rising preference for home care to drive demand 100 6.2.5 OXIMETERS 101 6.2.5.1 Increasing focus on self-monitoring to drive market 101 6.3 IMAGING SYSTEMS 102 6.3.1 NEED TO TRANSMIT DATA FOR REMOTE VIEWING TO SUPPORT MARKET GROWTH 102   6.4 IMPLANTABLE CARDIAC DEVICES 104 6.4.1 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS 105 6.4.1.1 Growing geriatric population to boost demand 105 6.4.2 PACEMAKERS 107 6.4.2.1 Rising number of cardiac patients to drive demand 107 6.4.3 IMPLANTABLE CARDIAC MONITORS 108 6.4.3.1 Ease of remote monitoring to drive demand 108 6.5 PATIENT MONITORS 109 6.5.1 GROWING ADOPTION TO BOOST MARKET 109 6.6 RESPIRATORY DEVICES 111 6.6.1 RISING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE DEMAND 111 6.7 INFUSION PUMPS 112 6.7.1 RISK OF SECURITY BREACHES TO IMPACT MARKET GROWTH 112 6.8 FETAL MONITORING DEVICES 113 6.8.1 GROWING EMPHASIS ON FETAL HEALTH TO DRIVE MARKET GROWTH 113 6.9 NEUROLOGICAL DEVICES 115 6.9.1 TECHNOLOGICAL ADVANCEMENTS TO BOOST MARKET 115 6.10 VENTILATORS 117 6.10.1 HIGH DEMAND FOR INTENSIVE CARE TO DRIVE MARKET GROWTH 117 6.11 ANESTHESIA MACHINES 118 6.11.1 INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET 118 6.12 HEARING DEVICES 119 6.12.1 RISING ADOPTION OF ADVANCED AIDS TO BOOST MARKET 119 6.13 OTHER IOT MEDICAL DEVICES 120 7 IOT MEDICAL DEVICES MARKET, BY TYPE 122 7.1 INTRODUCTION 123 7.2 STATIONARY DEVICES 123 7.2.1 IMPROVED DATA ACCESSIBILITY TO DRIVE DEMAND 123 7.3 IMPLANTABLE DEVICES 126 7.3.1 INCREASING INCIDENCE OF CVD AND NEUROLOGICAL DISEASES TO DRIVE DEMAND 126 7.4 WEARABLE DEVICES 128 7.4.1 RISING USE IN HOME CARE SETTINGS TO PROPEL MARKET 128 7.5 OTHER DEVICE TYPES 129 8 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY 131 8.1 INTRODUCTION 132 8.2 WI-FI 132 8.2.1 ABILITY TO PROVIDE GREATER FLEXIBILITY TO CAREGIVERS TO SUPPORT MARKET GROWTH 132   8.3 BLUETOOTH 133 8.3.1 SEAMLESS CONNECTION BETWEEN WIRELESS DEVICES TO FOSTER ADOPTION 133 8.4 ZIGBEE 134 8.4.1 SECURITY CONCERNS TO LIMIT ADOPTION 134 8.5 OTHER CONNECTIVITY TECHNOLOGIES 135 9 IOT MEDICAL DEVICES MARKET, BY END USER 136 9.1 INTRODUCTION 137 9.2 HOSPITALS & CLINICS 138 9.2.1 NEED TO REDUCE HEALTHCARE COSTS TO DRIVE MARKET 138 9.3 NURSING HOMES, ASSISTED LIVING FACILITIES, LONG-TERM CARE CENTERS, AND HOME CARE SETTINGS 139 9.3.1 INCREASING GERIATRIC POPULATION TO CONTRIBUTE TO SEGMENT GROWTH 139 9.4 OTHER END USERS 140 10 IOT MEDICAL DEVICES MARKET, BY REGION 141 10.1 INTRODUCTION 142 10.2 NORTH AMERICA 143 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 143 10.2.2 US 147 10.2.2.1 High adoption of connected devices to drive market 147 10.2.3 CANADA 150 10.2.3.1 Government investments in health-related technologies to boost market 150 10.3 EUROPE 153 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 154 10.3.2 GERMANY 157 10.3.2.1 Government initiatives to boost market 157 10.3.3 UK 160 10.3.3.1 High penetration of wearables to drive market 160 10.3.4 FRANCE 163 10.3.4.1 Government support for e-Health to drive market 163 10.3.5 ITALY 166 10.3.5.1 Widespread use of mobile devices to drive market 166 10.3.6 SPAIN 169 10.3.6.1 Growing geriatric population to propel demand 169 10.3.7 REST OF EUROPE 172 10.4 ASIA PACIFIC 175 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 175 10.4.2 CHINA 179 10.4.2.1 High burden of chronic disorders to drive demand 179   10.4.3 JAPAN 182 10.4.3.1 Demand from large geriatric population to boost market 182 10.4.4 INDIA 185 10.4.4.1 Growing adoption of telemedicine to boost market 185 10.4.5 REST OF ASIA PACIFIC 188 10.5 LATIN AMERICA 192 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 192 10.5.2 BRAZIL 196 10.5.2.1 Increasing government initiatives to drive market 196 10.5.3 MEXICO 199 10.5.3.1 Focus on digitalization of healthcare to support market 199 10.5.4 REST OF LATIN AMERICA 202 10.6 MIDDLE EAST & AFRICA 205 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 206 10.6.2 GCC COUNTRIES 209 10.6.3 REST OF MIDDLE EAST & AFRICA 212 11 COMPETITIVE LANDSCAPE 216 11.1 INTRODUCTION 216 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 216 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IOT MEDICAL DEVICES MARKET 217 11.3 REVENUE ANALYSIS, 2024 218 11.4 MARKET SHARE ANALYSIS, 2024 218 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 221 11.5.1 STARS 221 11.5.2 EMERGING LEADERS 221 11.5.3 PERVASIVE PLAYERS 221 11.5.4 PARTICIPANTS 221 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 223 11.5.5.1 Company footprint 223 11.5.5.2 Region footprint 224 11.5.5.3 Product footprint 225 11.5.5.4 Type footprint 226 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 227 11.6.1 PROGRESSIVE COMPANIES 227 11.6.2 RESPONSIVE COMPANIES 227 11.6.3 DYNAMIC COMPANIES 228 11.6.4 STARTING BLOCKS 228 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 229 11.6.5.1 Detailed list of key startups/SMEs 229   11.7 VALUATION & FINANCIAL METRICS 230 11.7.1 FINANCIAL METRICS 230 11.7.2 COMPANY VALUATION 230 11.8 BRAND/SOFTWARE COMPARISON 231 11.9 COMPETITIVE SCENARIO 232 11.9.1 PRODUCT LAUNCHES 232 11.9.2 DEALS 233 11.9.3 EXPANSIONS 233 12 COMPANY PROFILES 234 12.1 KEY COMPANIES 234 12.1.1 MEDTRONIC 234 12.1.1.1 Business overview 234 12.1.1.2 Products offered 235 12.1.1.3 Recent developments 238 12.1.1.3.1 Product launches & approvals 238 12.1.1.3.2 Deals 239 12.1.1.3.3 Other developments 240 12.1.1.4 MnM view 240 12.1.1.4.1 Key strengths/Right to win 240 12.1.1.4.2 Strategic choices 240 12.1.1.4.3 Weaknesses and competitive threats 241 12.1.2 GE HEALTHCARE 242 12.1.2.1 Business overview 242 12.1.2.2 Products offered 243 12.1.2.3 Recent developments 244 12.1.2.3.1 Product launches & approvals 244 12.1.2.3.2 Deals 245 12.1.2.4 MnM view 246 12.1.2.4.1 Key strengths/Right to win 246 12.1.2.4.2 Strategic choices 246 12.1.2.4.3 Weaknesses and competitive threats 246 12.1.3 KONINKLIJKE PHILIPS N.V. 247 12.1.3.1 Business overview 247 12.1.3.2 Products offered 248 12.1.3.3 Recent developments 249 12.1.3.3.1 Product launches & enhancements 249 12.1.3.3.2 Deals 251 12.1.3.3.3 Other developments 252   12.1.3.4 MnM view 252 12.1.3.4.1 Key strengths/Right to win 252 12.1.3.4.2 Strategic choices 253 12.1.3.4.3 Weaknesses and competitive threats 253 12.1.4 ABBOTT 254 12.1.4.1 Business overview 254 12.1.4.2 Products offered 255 12.1.4.3 Recent developments 256 12.1.4.3.1 Product launches & approvals 256 12.1.4.3.2 Deals 258 12.1.4.4 MnM view 259 12.1.4.4.1 Key strengths/Right to win 259 12.1.4.4.2 Strategic choices 259 12.1.4.4.3 Weaknesses and competitive threats 259 12.1.5 BOSTON SCIENTIFIC CORPORATION 260 12.1.5.1 Business overview 260 12.1.5.2 Products offered 262 12.1.5.3 Recent developments 264 12.1.5.3.1 Product launches, enhancements, and approvals 264 12.1.5.3.2 Deals 265 12.1.5.4 MnM view 266 12.1.5.4.1 Key strengths/Right to win 266 12.1.5.4.2 Strategic choices 266 12.1.5.4.3 Weaknesses and competitive threats 266 12.1.6 OMRON CORPORATION 267 12.1.6.1 Business overview 267 12.1.6.2 Products offered 268 12.1.6.3 Recent developments 269 12.1.6.3.1 Product & service launches 269 12.1.6.3.2 Deals 270 12.1.6.3.3 Expansions 270 12.1.7 BAXTER INTERNATIONAL, INC. 271 12.1.7.1 Business overview 271 12.1.7.2 Products offered 272 12.1.7.3 Recent developments 274 12.1.7.3.1 Product launches & approvals 274 12.1.7.3.2 Deals 276 12.1.8 BIOTRONIK 277 12.1.8.1 Business overview 277 12.1.8.2 Products offered 277 12.1.8.3 Recent developments 278 12.1.8.3.1 Product launches & enhancements 278 12.1.8.3.2 Deals 279 12.1.9 JOHNSON & JOHNSON 280 12.1.9.1 Business overview 280 12.1.9.2 Products offered 281 12.1.9.3 Recent developments 282 12.1.9.3.1 Deals 282 12.1.10 NIHON KOHDEN CORPORATION 283 12.1.10.1 Business overview 283 12.1.10.2 Products offered 284 12.1.10.3 Recent developments 285 12.1.10.3.1 Product launches & approvals 285 12.1.10.3.2 Deals 286 12.1.10.3.3 Expansions 286 12.1.11 SIEMENS HEALTHINEERS AG 287 12.1.11.1 Business overview 287 12.1.11.2 Products offered 288 12.1.11.3 Recent developments 288 12.1.11.3.1 Product launches 288 12.1.11.3.2 Deals 289 12.1.12 HONEYWELL INTERNATIONAL, INC. 290 12.1.12.1 Business overview 290 12.1.12.2 Products offered 291 12.1.13 ALIVECOR, INC. 292 12.1.13.1 Business overview 292 12.1.13.2 Products offered 292 12.1.13.3 Recent developments 293 12.1.13.3.1 Product & service launches 293 12.1.13.3.2 Deals 294 12.1.14 DRÄGERWERK AG & CO. KGAA 295 12.1.14.1 Business overview 295 12.1.14.2 Products offered 296 12.1.14.3 Recent developments 296 12.1.14.3.1 Product launches 296 12.1.14.3.2 Deals 297 12.1.15 NONIN 298 12.1.15.1 Business overview 298 12.1.15.2 Products offered 298 12.1.15.3 Recent developments 299 12.1.15.3.1 Product launches 299 12.1.15.3.2 Deals 299   12.1.16 RESMED 300 12.1.16.1 Business overview 300 12.1.16.2 Products offered 302 12.1.16.3 Recent developments 302 12.1.16.3.1 Product launches 302 12.1.16.3.2 Deals 303 12.1.16.3.3 Expansions 304 12.1.16.3.4 Other developments 304 12.1.17 MASIMO 305 12.1.17.1 Business overview 305 12.1.17.2 Products offered 306 12.1.17.3 Recent developments 308 12.1.17.3.1 Product launches & approvals 308 12.1.17.3.2 Deals 309 12.1.18 I-SENS, INC. 310 12.1.18.1 Business overview 310 12.1.18.2 Products offered 311 12.1.18.3 Recent developments 313 12.1.18.3.1 Product launches & approvals 313 12.1.18.3.2 Deals 313 12.1.18.3.3 Expansions 313 12.1.19 ICU MEDICAL, INC. 314 12.1.19.1 Business overview 314 12.1.19.2 Products offered 315 12.1.19.3 Recent developments 316 12.1.19.3.1 Product approvals 316 12.1.19.3.2 Deals 316 12.2 OTHER PLAYERS 317 12.2.1 AMD GLOBAL TELEMEDICINE 317 12.2.2 IHEALTH LABS 317 12.2.3 AEROTEL MEDICAL SYSTEMS 318 12.2.4 HUNTLEIGH HEALTHCARE LIMITED 319 12.2.5 INFINIUM MEDICAL 319 12.2.6 HAMILTON MEDICAL 320 13 APPENDIX 321 13.1 DISCUSSION GUIDE 321 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 326 13.3 CUSTOMIZATION OPTIONS 328 13.4 RELATED REPORTS 328 13.5 AUTHOR DETAILS 329
圖表清單 List of Tables & Figures
TABLE 1 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ON IOT MEDICAL DEVICES MARKET 51 TABLE 2 MAJOR US HEALTHCARE DATA BREACHES 57 TABLE 3 IOT MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 64 TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 65 TABLE 5 KEY BUYING CRITERIA FOR IOT MEDICAL DEVICES 66 TABLE 6 TESTS AND CERTIFICATION REQUIREMENTS FOR WIRELESSLY CONNECTED MEDICAL DEVICES 67 TABLE 7 REGULATIONS AND STANDARDS GOVERNING CONNECTED MEDICAL DEVICES 70 TABLE 8 CLASSIFICATION OF MEDICAL DEVICES IN JAPAN 72 TABLE 9 CLASSIFICATION OF MEDICAL DEVICES IN CHINA 73 TABLE 10 AVERAGE COST OF IOT MEDICAL DEVICES, BY PRODUCT 75 TABLE 11 KEY PATENTS IN IOT MEDICAL DEVICES MARKET 78 TABLE 12 IOT MEDICAL DEVICES MARKET: LIST OF CONFERENCES AND EVENTS 81 TABLE 13 US ADJUSTED RECIPROCAL TARIFF RATES 83 TABLE 14 IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 92 TABLE 15 VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 93 TABLE 16 VITAL SIGNS MONITORING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 93 TABLE 17 BLOOD GLUCOSE MONITORS OFFERED BY KEY MARKET PLAYERS 94 TABLE 18 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION) 95 TABLE 19 ECG/HEART RATE MONITORS OFFERED BY KEY MARKET PLAYERS 96 TABLE 20 ECG/HEART RATE MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION) 97 TABLE 21 BLOOD PRESSURE MONITORS OFFERED BY KEY MARKET PLAYERS 98 TABLE 22 BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 23 MULTIPARAMETER MONITORS OFFERED BY KEY MARKET PLAYERS 100 TABLE 24 MULTIPARAMETER MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION) 101 TABLE 25 OXIMETERS OFFERED BY KEY MARKET PLAYERS 101 TABLE 26 OXIMETERS MARKET, BY REGION, 2023–2030 (USD MILLION) 102 TABLE 27 IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 103 TABLE 28 IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 29 IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 104 TABLE 30 IMPLANTABLE CARDIAC DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 104 TABLE 31 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS OFFERED BY KEY MARKET PLAYERS 105 TABLE 32 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 106 TABLE 33 PACEMAKERS OFFERED BY KEY MARKET PLAYERS 107 TABLE 34 PACEMAKERS MARKET, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 35 IMPLANTABLE CARDIAC MONITORS OFFERED BY KEY MARKET PLAYERS 108 TABLE 36 IMPLANTABLE CARDIAC MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 37 PATIENT MONITORS OFFERED BY KEY MARKET PLAYERS 109 TABLE 38 PATIENT MONITORS MARKET, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 39 RESPIRATORY DEVICES OFFERED BY KEY MARKET PLAYERS 111 TABLE 40 RESPIRATORY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 41 INFUSION PUMPS OFFERED BY KEY MARKET PLAYERS 113 TABLE 42 INFUSION PUMPS MARKET, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 43 FETAL MONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 114 TABLE 44 FETAL MONITORING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 45 NEUROLOGICAL DEVICES OFFERED BY KEY MARKET PLAYERS 116 TABLE 46 NEUROLOGICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 47 VENTILATORS OFFERED BY KEY MARKET PLAYERS 117 TABLE 48 VENTILATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 49 ANESTHESIA MACHINES OFFERED BY KEY MARKET PLAYERS 118 TABLE 50 ANESTHESIA MACHINES MARKET, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 51 HEARING DEVICES OFFERED BY KEY MARKET PLAYERS 119 TABLE 52 HEARING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 53 OTHER IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS 120 TABLE 54 OTHER IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 55 IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 123 TABLE 56 STATIONARY IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS 124 TABLE 57 STATIONARY IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 58 IMPLANTABLE IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS 126 TABLE 59 IMPLANTABLE IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 60 WEARABLE IOT MEDICAL DEVICES OFFERED BY KEY MARKET PLAYERS 128 TABLE 61 WEARABLE IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 62 OTHER DEVICE TYPES OFFERED BY KEY MARKET PLAYERS 130 TABLE 63 OTHER IOT MEDICAL DEVICE TYPES MARKET, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 64 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 132 TABLE 65 WI-FI-ENABLED IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 66 BLUETOOTH-ENABLED IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 67 ZIGBEE-ENABLED IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 68 OTHER IOT MEDICAL DEVICE CONNECTIVITY TECHNOLOGIES MARKET, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 69 IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 137 TABLE 70 IOT MEDICAL DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 71 IOT MEDICAL DEVICES MARKET FOR NURSING HOMES, ASSISTED LIVING FACILITIES, LONG-TERM CARE CENTERS, AND HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 72 IOT MEDICAL DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 73 IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 74 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 75 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 145 TABLE 76 NORTH AMERICA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 77 NORTH AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 78 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 79 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 146 TABLE 80 NORTH AMERICA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 81 US: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 148 TABLE 82 US: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 148 TABLE 83 US: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 84 US: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 85 US: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 149 TABLE 86 US: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 150 TABLE 87 CANADA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 151 TABLE 88 CANADA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 89 CANADA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 90 CANADA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 91 CANADA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 152 TABLE 92 CANADA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 153 TABLE 93 EUROPE: IOT MEDICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 94 EUROPE: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 155 TABLE 95 EUROPE: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 155 TABLE 96 EUROPE: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 156   TABLE 97 EUROPE: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 98 EUROPE: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 156 TABLE 99 EUROPE: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 157 TABLE 100 GERMANY: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 158 TABLE 101 GERMANY: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 102 GERMANY: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 103 GERMANY: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 104 GERMANY: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 159 TABLE 105 GERMANY: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 106 UK: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161 TABLE 107 UK: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 108 UK: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 109 UK: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 110 UK: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 162 TABLE 111 UK: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 112 FRANCE: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 164 TABLE 113 FRANCE: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 114 FRANCE: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 115 FRANCE: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 116 FRANCE: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 165 TABLE 117 FRANCE: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 166 TABLE 118 ITALY: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 167 TABLE 119 ITALY: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 120 ITALY: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 121 ITALY: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 122 ITALY: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 168 TABLE 123 ITALY: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 124 SPAIN: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 170 TABLE 125 SPAIN: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 170   TABLE 126 SPAIN: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 127 SPAIN: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 128 SPAIN: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 171 TABLE 129 SPAIN: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 130 REST OF EUROPE: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 173 TABLE 131 REST OF EUROPE: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 132 REST OF EUROPE: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 133 REST OF EUROPE: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 134 REST OF EUROPE: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 174 TABLE 135 REST OF EUROPE: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 136 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 137 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 177 TABLE 138 ASIA PACIFIC: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 139 ASIA PACIFIC: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 140 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 141 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 179 TABLE 142 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 143 CHINA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 180 TABLE 144 CHINA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 145 CHINA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 146 CHINA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 147 CHINA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 182 TABLE 148 CHINA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 149 JAPAN: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 183 TABLE 150 JAPAN: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 151 JAPAN: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 152 JAPAN: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 153 JAPAN: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 185   TABLE 154 JAPAN: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 185 TABLE 155 INDIA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 186 TABLE 156 INDIA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 157 INDIA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 158 INDIA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 159 INDIA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 188 TABLE 160 INDIA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 188 TABLE 161 REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 189 TABLE 162 REST OF ASIA PACIFIC: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 163 REST OF ASIA PACIFIC: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 164 REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 165 REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 191 TABLE 166 REST OF ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 167 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 168 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 193 TABLE 169 LATIN AMERICA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 170 LATIN AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 171 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 172 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 195 TABLE 173 LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 196 TABLE 174 BRAZIL: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 197 TABLE 175 BRAZIL: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 176 BRAZIL: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 177 BRAZIL: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 178 BRAZIL: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 198 TABLE 179 BRAZIL: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 199 TABLE 180 MEXICO: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 200   TABLE 181 MEXICO: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 182 MEXICO: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 183 MEXICO: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 184 MEXICO: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 201 TABLE 185 MEXICO: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 202 TABLE 186 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 203 TABLE 187 REST OF LATIN AMERICA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 188 REST OF LATIN AMERICA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 189 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 190 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 204 TABLE 191 REST OF LATIN AMERICA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 205 TABLE 192 MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 206 TABLE 193 MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 207 TABLE 194 MIDDLE EAST & AFRICA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 195 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 196 MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 197 MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 208 TABLE 198 MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 209 TABLE 199 GCC COUNTRIES: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 210 TABLE 200 GCC COUNTRIES: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 201 GCC COUNTRIES: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 202 GCC COUNTRIES: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 203 GCC COUNTRIES: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 211 TABLE 204 GCC COUNTRIES: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 212 TABLE 205 REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 213   TABLE 206 REST OF MIDDLE EAST & AFRICA: VITAL SIGNS MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 207 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE CARDIAC DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 208 REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 209 REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2023–2030 (USD MILLION) 215 TABLE 210 REST OF MIDDLE EAST & AFRICA: IOT MEDICAL DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 215 TABLE 211 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IOT MEDICAL DEVICES MARKET, JANUARY 2022–MAY 2025 217 TABLE 212 IOT MEDICAL DEVICES MARKET: DEGREE OF COMPETITION 219 TABLE 213 IOT MEDICAL DEVICES MARKET: REGION FOOTPRINT 224 TABLE 214 IOT MEDICAL DEVICES MARKET: PRODUCT FOOTPRINT 225 TABLE 215 IOT MEDICAL DEVICES MARKET: TYPE FOOTPRINT 226 TABLE 216 IOT MEDICAL DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 229 TABLE 217 IOT MEDICAL DEVICES MARKET: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 232 TABLE 218 IOT MEDICAL DEVICES MARKET: DEALS, JANUARY 2022–MAY 2025 233 TABLE 219 IOT MEDICAL DEVICES MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 233 TABLE 220 MEDTRONIC: BUSINESS OVERVIEW 234 TABLE 221 MEDTRONIC: PRODUCTS OFFERED 235 TABLE 222 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 238 TABLE 223 MEDTRONIC: DEALS, JANUARY 2022–MAY 2025 239 TABLE 224 MEDTRONIC: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2025 240 TABLE 225 GE HEALTHCARE: BUSINESS OVERVIEW 242 TABLE 226 GE HEALTHCARE: PRODUCTS OFFERED 243 TABLE 227 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 244 TABLE 228 GE HEALTHCARE DEALS, JANUARY 2022–MAY 2025 245 TABLE 229 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 247 TABLE 230 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 248 TABLE 231 KONINKLIJKE PHILIPS N.V: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 249 TABLE 232 KONINKLIJKE PHILIPS N.V: DEALS, JANUARY 2022–MAY 2025 251 TABLE 233 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 252 TABLE 234 ABBOTT: BUSINESS OVERVIEW 254 TABLE 235 ABBOTT: PRODUCTS OFFERED 255 TABLE 236 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 256 TABLE 237 ABBOTT: DEALS, JANUARY 2022–MAY 2025 258 TABLE 238 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 260 TABLE 239 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 262 TABLE 240 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022–MAY 2025 264   TABLE 241 BOSTON SCIENTIFIC: DEALS, JANUARY 2022–MAY 2025 265 TABLE 242 OMRON CORPORATION: BUSINESS OVERVIEW 267 TABLE 243 OMRON CORPORATION: PRODUCTS OFFERED 268 TABLE 244 OMRON CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2022–MAY 2025 269 TABLE 245 OMRON CORPORATION: DEALS, OMRON CORPORATION 270 TABLE 246 OMRON CORPORATION: EXPANSIONS, OMRON CORPORATION 270 TABLE 247 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW 271 TABLE 248 BAXTER INTERNATIONAL, INC.: PRODUCTS OFFERED 272 TABLE 249 BAXTER INTERNATIONAL, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 274 TABLE 250 BAXTER: DEALS, JANUARY 2022–MAY 2025 276 TABLE 251 BIOTRONIK: BUSINESS OVERVIEW 277 TABLE 252 BIOTRONIK: PRODUCTS OFFERED 277 TABLE 253 BIOTRONIK PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MAY 2025 278 TABLE 254 BIOTRONIK: DEALS, JANUARY 2022–MAY 2025 279 TABLE 255 JOHNSON & JOHNSON: BUSINESS OVERVIEW 280 TABLE 256 JOHNSON & JOHNSON: PRODUCTS OFFERED 281 TABLE 257 JOHNSON & JOHNSON: DEALS, JANUARY 2022–MAY 2025 282 TABLE 258 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 283 TABLE 259 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 284 TABLE 260 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 285 TABLE 261 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2022–MAY 2025 286 TABLE 262 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2025 286 TABLE 263 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 287 TABLE 264 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 288 TABLE 265 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 288 TABLE 266 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–MAY 2025 289 TABLE 267 HONEYWELL INTERNATIONAL, INC.: BUSINESS OVERVIEW 290 TABLE 268 HONEYWELL INTERNATIONAL, INC.: PRODUCTS OFFERED 291 TABLE 269 ALIVECOR, INC.: BUSINESS OVERVIEW 292 TABLE 270 ALIVECOR, INC.: PRODUCTS OFFERED 292 TABLE 271 ALIVECOR, INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2022–MAY 2025 293 TABLE 272 ALIVECOR, INC.: DEALS, JANUARY 2022–MAY 2025 294 TABLE 273 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW 295 TABLE 274 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 296 TABLE 275 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 296 TABLE 276 DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2022–MAY 2025 297 TABLE 277 NONIN: BUSINESS OVERVIEW 298 TABLE 278 NONIN: PRODUCTS OFFERED 298 TABLE 279 NONIN: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 299 TABLE 280 NONIN: DEALS, JANUARY 2022–MAY 2025 299   TABLE 281 RESMED: COMPANY OVERVIEW 300 TABLE 282 RESMED: PRODUCTS OFFERED 302 TABLE 283 RESMED: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025 302 TABLE 284 RESMED: DEALS, JANUARY 2022–MAY 2025 303 TABLE 285 RESMED: EXPANSIONS, JANUARY 2022–MAY 2025 304 TABLE 286 RESMED: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 304 TABLE 287 MASIMO: COMPANY OVERVIEW 305 TABLE 288 MASIMO: PRODUCTS OFFERED 306 TABLE 289 MASIMO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 308 TABLE 290 MASIMO: DEALS, JANUARY 2022–MAY 2025 309 TABLE 291 I-SENS, INC.: COMPANY OVERVIEW 310 TABLE 292 I-SENS, INC.: PRODUCTS OFFERED 311 TABLE 293 I-SENS, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 313 TABLE 294 I-SENS, INC.: DEALS, JANUARY 2022–MAY 2025 313 TABLE 295 I-SENS, INC.: EXPANSIONS, JANUARY 2022–MAY 2025 313 TABLE 296 ICU MEDICAL, INC.: COMPANY OVERVIEW 314 TABLE 297 ICU MEDICAL, INC.: PRODUCTS OFFERED 315 TABLE 298 ICU MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025 316 TABLE 299 ICU MEDICAL, INC.: DEALS, JANUARY 2022–MAY 2025 316 FIGURE 1 RESEARCH DESIGN 32 FIGURE 2 PRIMARY SOURCES 33 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS DEMAND SIDE AND SUPPLY SIDE: BY COMPANY TYPE, DESIGNATION, AND REGION 35 FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 36 FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37 FIGURE 6 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38 FIGURE 7 BOTTOM-UP APPROACH 38 FIGURE 8 TOP-DOWN APPROACH 39 FIGURE 9 DATA TRIANGULATION METHODOLOGY 39 FIGURE 10 IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2025 VS. 2030(USD MILLION) 42 FIGURE 11 IOT MEDICAL DEVICES MARKET, BY TYPE, 2025 VS. 2030(USD MILLION) 43 FIGURE 12 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 43 FIGURE 13 IOT MEDICAL DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 44 FIGURE 14 GEOGRAPHICAL SNAPSHOT OF IOT MEDICAL DEVICES MARKET 45 FIGURE 15 RISING GLOBAL DEMAND FOR REMOTE PATIENT MONITORING TO DRIVE MARKET GROWTH 46 FIGURE 16 STATIONARY MEDICAL DEVICES TO COMMAND LARGEST SHARE OF ASIA PACIFIC MARKET IN 2024 47 FIGURE 17 CHINA TO RECORD HIGHEST CAGR IN GLOBAL MARKET 48 FIGURE 18 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 48 FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES 49 FIGURE 20 IOT MEDICAL DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50 FIGURE 21 HEALTHCARE SPENDING, BY COUNTRY, 2023 (% OF GDP) 52 FIGURE 22 NUMBER OF SMARTPHONE USERS, BY COUNTRY, 2022 54 FIGURE 23 IOT MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 63 FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 65 FIGURE 25 KEY BUYING CRITERIA FOR IOT MEDICAL DEVICES 66 FIGURE 26 VALUE CHAIN ANALYSIS, 2024 74 FIGURE 27 IOT MEDICAL DEVICES MARKET: ECOSYSTEM 75 FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2015–MAY 2025) 76 FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) OF IOT MEDICAL DEVICES (JANUARY 2015–MAY 2025) 77 FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR IOT MEDICAL DEVICE PATENTS (JANUARY 2015–MAY 2025) 78 FIGURE 31 IOT MEDICAL DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82   FIGURE 32 NORTH AMERICA: IOT MEDICAL DEVICES MARKET SNAPSHOT 144 FIGURE 33 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET SNAPSHOT 176 FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2024 218 FIGURE 35 IOT MEDICAL DEVICES MARKET: MARKET SHARE ANALYSIS, 2024 219 FIGURE 36 IOT MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 222 FIGURE 37 IOT MEDICAL DEVICES MARKET: COMPANY FOOTPRINT 223 FIGURE 38 IOT MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 228 FIGURE 39 EV/EBITDA OF KEY VENDORS 230 FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 230 FIGURE 41 IOT MEDICAL DEVICES MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 231 FIGURE 42 MEDTRONIC: COMPANY SNAPSHOT (2023) 235 FIGURE 43 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 243 FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 247 FIGURE 45 ABBOTT: COMPANY SNAPSHOT (2024) 255 FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 261 FIGURE 47 OMRON CORPORATION: COMPANY SNAPSHOT (2024) 267 FIGURE 48 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2024) 272 FIGURE 49 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2024) 281 FIGURE 50 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2024) 284 FIGURE 51 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 287 FIGURE 52 HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT (2024) 291 FIGURE 53 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2024) 295 FIGURE 54 RESMED: COMPANY SNAPSHOT (2024) 301 FIGURE 55 MASIMO: COMPANY SNAPSHOT (2024) 306 FIGURE 56 I-SENS, INC.: COMPANY SNAPSHOT (2024) 311 FIGURE 57 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 315 FIGURE 1 RESEARCH DESIGN 32 FIGURE 2 PRIMARY SOURCES 33 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS DEMAND SIDE AND SUPPLY SIDE: BY COMPANY TYPE, DESIGNATION, AND REGION 35 FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 36 FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37 FIGURE 6 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38 FIGURE 7 BOTTOM-UP APPROACH 38 FIGURE 8 TOP-DOWN APPROACH 39 FIGURE 9 DATA TRIANGULATION METHODOLOGY 39 FIGURE 10 IOT MEDICAL DEVICES MARKET, BY PRODUCT, 2025 VS. 2030(USD MILLION) 42 FIGURE 11 IOT MEDICAL DEVICES MARKET, BY TYPE, 2025 VS. 2030(USD MILLION) 43 FIGURE 12 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 43 FIGURE 13 IOT MEDICAL DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 44 FIGURE 14 GEOGRAPHICAL SNAPSHOT OF IOT MEDICAL DEVICES MARKET 45 FIGURE 15 RISING GLOBAL DEMAND FOR REMOTE PATIENT MONITORING TO DRIVE MARKET GROWTH 46 FIGURE 16 STATIONARY MEDICAL DEVICES TO COMMAND LARGEST SHARE OF ASIA PACIFIC MARKET IN 2024 47 FIGURE 17 CHINA TO RECORD HIGHEST CAGR IN GLOBAL MARKET 48 FIGURE 18 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 48 FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES 49 FIGURE 20 IOT MEDICAL DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50 FIGURE 21 HEALTHCARE SPENDING, BY COUNTRY, 2023 (% OF GDP) 52 FIGURE 22 NUMBER OF SMARTPHONE USERS, BY COUNTRY, 2022 54 FIGURE 23 IOT MEDICAL DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 63 FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 65 FIGURE 25 KEY BUYING CRITERIA FOR IOT MEDICAL DEVICES 66 FIGURE 26 VALUE CHAIN ANALYSIS, 2024 74 FIGURE 27 IOT MEDICAL DEVICES MARKET: ECOSYSTEM 75 FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2015–MAY 2025) 76 FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) OF IOT MEDICAL DEVICES (JANUARY 2015–MAY 2025) 77 FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR IOT MEDICAL DEVICE PATENTS (JANUARY 2015–MAY 2025) 78 FIGURE 31 IOT MEDICAL DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82   FIGURE 32 NORTH AMERICA: IOT MEDICAL DEVICES MARKET SNAPSHOT 144 FIGURE 33 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET SNAPSHOT 176 FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2024 218 FIGURE 35 IOT MEDICAL DEVICES MARKET: MARKET SHARE ANALYSIS, 2024 219 FIGURE 36 IOT MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 222 FIGURE 37 IOT MEDICAL DEVICES MARKET: COMPANY FOOTPRINT 223 FIGURE 38 IOT MEDICAL DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 228 FIGURE 39 EV/EBITDA OF KEY VENDORS 230 FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 230 FIGURE 41 IOT MEDICAL DEVICES MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 231 FIGURE 42 MEDTRONIC: COMPANY SNAPSHOT (2023) 235 FIGURE 43 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 243 FIGURE 44 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 247 FIGURE 45 ABBOTT: COMPANY SNAPSHOT (2024) 255 FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 261 FIGURE 47 OMRON CORPORATION: COMPANY SNAPSHOT (2024) 267 FIGURE 48 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2024) 272 FIGURE 49 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2024) 281 FIGURE 50 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2024) 284 FIGURE 51 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 287 FIGURE 52 HONEYWELL INTERNATIONAL, INC.: COMPANY SNAPSHOT (2024) 291 FIGURE 53 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2024) 295 FIGURE 54 RESMED: COMPANY SNAPSHOT (2024) 301 FIGURE 55 MASIMO: COMPANY SNAPSHOT (2024) 306 FIGURE 56 I-SENS, INC.: COMPANY SNAPSHOT (2024) 311 FIGURE 57 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 315

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們